Add like
Add dislike
Add to saved papers

Executive Functions and Motor Adaptation to Predictable and Unpredictable Perturbations.

In this study, we aimed to investigate the influence of executive functions (EF) on motor adaptation. We compared the motor performance of adults with and without EF deficits. Those with EF deficits ( n = 21) were individuals with attention deficit hyperactivity disorder (ADHD) under medical treatment, and those without EF deficits ( n = 21) comprised a control group (CG) of participants who were also without neurological or psychiatric diagnoses. Both groups performed a complex coincident timing motor task and various computerized neuropsychological tests for assessing EF. To investigate motor adaptation, the motor task provided measures of absolute error (AE) and variable error (VE) to reflect, respectively, performance accuracy and consistency relative to the task goal. We used reaction time (RT) to measure planning time taken before starting the task. First, participants practiced until they reached a criterion of performance stabilization (prior to their exposure to motor perturbations). They were next exposed to fast and slow predictable and unpredictable perturbations. On all neuropsychological tasks, participants with ADHD scored more poorly than control participants ( p < .05); participants with ADHD also performed worse than control participants on all motor measures, particularly under unpredictable perturbations ( p < .05). Under slow perturbations, EF deficits, particularly attentional impulsivity, negatively affected motor adaptation while cognitive flexibility was related to performance improvement. Under fast perturbations, both impulsivity and fast reaction time were related to improvement in motor adaptation under both predictable and unpredictable perturbations. We discuss the research and practical implications of these findings.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app